HealthinationA Quick Guide for the Coronavirus Outbreak.On March 11, WHO officially declared COVID-19 a pandemic. With much of the country taking steps to open up now or in the near future, hopes are ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, ...

Patients with multiple sclerosis (MS) who were receiving disease-modifying therapies were found to have rare occurrences of ...

CHICAGO (NewsNation Now) — The U.S. Food and Drug Administration (FDA) issued an emergency use approval for Abbott’s latest lab-based COVID-19 IgM antibody test, the company announced Monday. Abbott ...

Individuals with comorbidities, particularly type 2 diabetes (T2D), were considered the most vulnerable subgroups during the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute ...

Reported COVID-19 cases and deaths in many low- and middle-income countries (LMICs) have been fewer than initially anticipated. However, even relatively small surges in COVID-19 infections in an LMIC ...

As access to COVID-19 vaccines dwindles in the US, one company seems to be positioning its products as an alternative way of preventing the disease. Invivyd is the manufacturer of pemivibart, a ...

A recent Scientific Reports study evaluated the humoral response in the elderly population after receiving the fourth mRNA vaccine against coronavirus disease 2019 (COVID-19). Study: Antibody response ...

Some COVID-19 patients are testing positive after recovering in Asia, but experts say the presence of antibodies should guarantee short-term immunity ...

Such a treatment also may help determine how many people were exposed. With a limited supply of COVID-19 tests in the United States, people with mild symptoms are less likely to be tested, leaving ...